SEC Form D private-offering filing
Somite Therapeutics, Inc.
A new SEC Form D private-offering notice from Boston, MA, a $47,499,943 filer-stated offering target in Biotech. The source filing is one click away.
AI native TechBio company building foundation models, including its DeltaStem platform, to accelerate production of human cells for cell replacement therapies such as beta cells for type 1 diabetes and satellite cells for muscular dystrophy.
Filed 2025-11-26Filed to raise $47,499,943First money in 2025-04-11Raised so far $47,499,943HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified cellularintelligence.com↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.